Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1β and tumor necrosis factor a in human gingival fibroblasts

Journal of Dental Research

Volumn 78, Issue 1, 1999, Pages 61-68

  Yucel Lindberg, T ^a,b   Nilsson, S ^a   Modeer T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Karo Bio   (Sweden)

Author keywords

Gingival fibroblasts; IL 1 ; PGE2; TNF

Indexed keywords

ARACHIDONIC ACID; AUTACOID; CYCLIC AMP; CYCLOOXYGENASE 2; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; PHOSPHOLIPASE A; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; PTGS2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHILD; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; FIBROBLAST; GINGIVA; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; CELLS, CULTURED; CHILD; CYCLIC AMP; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG SYNERGISM; ENZYME ACTIVATION; EPOPROSTENOL; FIBROBLASTS; GINGIVA; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033278155     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345990780010901     Document Type: Article

References (48)

1. 2 stimulation. Exp Cell Res 222:379-384.
2. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516-518.
3. Blanco A, Habib A, Levy-Toledano S, Maclouf J (1995). Involvement of tyrosine kinases in the induction of cyclooxygenase-2 in human endothelial cells. Biochem J 312:419-423.
4. Brunius G, Yucel-Lindberg T, Shinoda K, Modéer T (1996). Effect of phenytoin on interleukin-1β production in human gingival fibroblasts challenged to tumor necrosis factor a in vitro. Eur J Oral Sci 104:27-33.
5. Burch RM, White MF, Connor JR (1989). Interleukin 1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interactions between two second messenger systems. J Cell Physiol 139:29-33.
6. 2 production in human fibroblasts. J Exp Med 174:1363-1369.
7. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, et al. (1996). Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270:1581-1587.
8. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168.
9. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 22:1-2.
10. DeWitt DL (1991). Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083:121-134.
11. Dinarello CA (1988). Biology of interleukin 1. FASEB 2:108-115.
12. Durnam DM, Palmiter RD (1983). A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 131:385-393.
13. Elias JA, Gustilo K, Baeder W, Freundlich B (1987). Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol 138:3812-3816.
14. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
15. Gowen M, Mundy GR (1986). Actions of recombinant interleukin 1, interleukin 2, and interferon-γ on bone resorption in vitro. J Immunol 136:2478-2482.
16. Guy GR, Chua SP, Wong NS, Ng SB, Tan YH (1991). Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J Biol Chem 266:14343-14352.
17. Harigai M, Hara M, Kitani A, Norioka K, Hirose T, Hirose W, et al. (1991). Interleukin 1 and tumor necrosis factor-α synergistically increase the production of interleukin 6 in human synovial fibroblast. J Clin Lab Immunol 34:107-113.
18. Henderson B, Blake S (1992). Therapeutic potential of cytokine manipulation. Trends Pharmacol Sci 13:145-152.
19. Le J, Vilcek J (1987). Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 56:234-248.
20. Maier JA, Ragnotti G (1993). An oligomer targeted against protein kinase C alpha prevents interleukin-1 alpha induction of cyclooxygenase expression in human endothelial cells. Exp Cell Res 205:52-58.
21. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, et al. (1994). In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharm Exp Ther 270:1340-1344.
22. Miralpeix M, Camacho M, López-Belmonte J, Canalías F, Beleta J, Palacios JM, et al. (1997). Selective induction of cyclooxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. Br J Pharmacol 121:171-180.
23. Mizel SB (1990). How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction. Immunol Today 11:390-391.
24. Mizel SB, Dayer JM, Krane SM, Mergenhagen SE (1981). Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (Interleukin-1). Proc Natl Acad Sci USA 78:2474-2477.
25. Modéer T, Dahllöf G, Otteskog P (1982). The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro. Acta Odontol Scand 40:353-357.
26. Modéer T, Brunius G, Iinuma M, Lerner UH (1992). Phenytoin potentiates interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Br J Pharmacol 106:574-578.
27. Modéer T, Yucel-Lindberg T, Iinuma M, Lerner UH, Andersson G (1993). Epidermal growth factor potentiates interleukin 1 and tumor necrosis factor-induced prostaglandin biosynthesis in human gingival fibroblasts. Cytokine 5:198-204.
28. 2. J Biol Chem 268:839-844.
29. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 60:67-78.
30. Norstedt G, Levinovitz A, Möller C, Eriksson LC, Andersson G (1988). Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, prolifera-tion and carcinogenesis in the rat. Carcinogenesis 9:209-213.
31. Offenbacher S, Odle BM, Gray RC, Van Dyke TE (1984). Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patient. J Periodont Res 19:1-13.
32. 2 secretion as a determinant of periodontal disease expression. J Periodontol 64:432-444.
33. Page RC (1991). The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 26:230-242.
34. Pfeilschifter J, Pignat W, Vosbeck K, Märki F (1989). Interleukin 1 and tumor necrosis factor synergistically stimulate
35. 2 release from rat renal mesangial cells. Biochem Biophys Res Commun 159:385-394.
36. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92:2516-2523.
37. Richards D, Rutherford RB (1988). The effects of interleukin 1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblasts. Arch Oral Biol 33:237-243.
38. 2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 180:46-52.
39. 2 and protein synthesis is blocked by dexamethasone in rat mesangial cells. FEBS Lett 333:339-343.
40. Schütze S, Nottrott S, Pfizenmaier K, Krönke M (1990). Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C. J Immunol 144:2604-2608.
41. Schütze S, Machleidt T, Krönke M (1994). The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukocyte Biol 56:533-541.
42. Smith WL, Garavito RM, DeWitt DL (1996). Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157-33160.
43. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987). Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464-1468.
44. Takigawa M, Takashiba S, Myokai F, Takahashi K, Arai H, Kurihara H, et al. (1994). Cytokine-dependent synergistic regulation of interleukin-8 production from human gingival fibroblasts. J Periodontol 65:1002-1007.
45. 2 stimulates prostaglandin synthesis in mouse osteoblastic cells (MC3T3-E1) via a specific binding site. J Biol Chem 268:2865-2871.
46. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, et al. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
47. Yucel-Lindberg T, Ahola H, Nilsson S, Carlstedt-Duke J, Modéer T (1995). Interleukin-1β induces expression of cyclooxygenase-2 mRNA in human gingival fibroblasts. Inflammation 19:549-560.
48. Zhang YH, Lin J-X, Yip YK, Vilcek J (1988). Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: Role in the induction of interleukin 6. Proc Natl Acad Sci USA 85:6802-6805.